← Back to home

RECURRENT TRANSFORMED MARGINAL ZONE LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA

Clinical trials for RECURRENT TRANSFORMED MARGINAL ZONE LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT TRANSFORMED MARGINAL ZONE LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for RECURRENT TRANSFORMED MARGINAL ZONE LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New Two-Pronged attack tested for Tough-to-Treat lymphoma that returns

Disease control Recruiting now

This study is testing a new treatment sequence for adults whose aggressive large B-cell lymphoma has come back or didn't respond to initial therapy. Participants first receive two targeted drugs (tafasitamab and lenalidomide), followed by a stronger chemotherapy regimen. The main…

Matched conditions: RECURRENT TRANSFORMED MARGINAL ZONE LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA

Phase: PHASE2 • Sponsor: David Bond, MD • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

RECURRENT TRANSFORMED MARGINAL ZONE LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA

Get alerted when new RECURRENT TRANSFORMED MARGINAL ZONE LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA trials appear

New Two-Pronged attack tested for Tough-to-Treat lymphoma that returns